Objective: To provide psychiatrists with relevant, up to date information about sporadic Creutzfeldt-Jakob disease.
Conclusions: A 59-year-old bookkeeper presented with psychiatric symptoms in the context of stressors and past history of depression, for which her GP prescribed sertraline and olanzapine. Following a further deterioration in her mental state she was referred to acute psychiatric services, and there found to have dementia and myoclonus, and investigations supported a diagnosis of probable Creutzfeldt-Jakob disease, sporadic type (sCJD). This paper serves to outline the emerging literature challenging the notion that suggests psychiatric symptoms are uncommon in the presentation of sCJD.
PrusinerS. Novel proteinaceous infectious particles cause scrapie. Science1982; 216: 136–144.
2.
WillRMatthewsW. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970–79. I: Clinical features. J Neurol Neurosurg Psychiatry1984; 47: 134–140.
3.
ZeidlerMJohnstoneEBamberR. New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet1997; 350: 908–910.
4.
ZerrIPoserS. Clinical diagnosis and differential diagnosis of CJD and vCJD. APMIS2002; 110: 88–98.
5.
WallCRummansTAksamitAKrahnLPankratzV. Psychiatric manifestations of Creutzfeldt-Jakob disease: a 25-year analysis. J Neuropsychiatry Clin Neurosci2005; 17: 489–495.
6.
ApplebyBApplebyKRabinsP. Does the presentation of Creutzfeldt-Jakob disease vary by age or presumed aetiology? A meta-analysis of the past 10 years. J Neuropsychiatry Clin Neurosci2007; 19: 428–435.
7.
World Health Organization. Global surveillance, diagnosis and therapy of human Transmissible Spongiform Encephalopathies: Report of a WHO consultation (WHO/EMC/ZDI/98/9). Geneva: WHO, 1998 (available from www.who.int/csr/resources/publications/bse/WHO_EMC_ZDI_98_9/en/).
ParchiPGieseACapellariS. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol1999; 46: 224–233.
13.
LewisVHillAFKlugGM. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles. Neurology2005; 65: 113–118.
14.
CollinsSJSanchez-JuanPMastersCL. Determinants of diagnostic investigation sensitivities across clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain2006; 129: 2278–2287.
TschampaHNeumannMZerrI. Patients with Alzheimer’s disease and dementia with Lewy bodies mistaken for Creuzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry2001; 71: 33–39.
